Ardent Health Partners Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
27 Feb
Ardent Health Partners Inc reports results for the quarter ended December 31 - Earnings Summary
  • Ardent Health Partners Inc ARDT.N reported quarterly adjusted earnings of 81 cents​​ per share for the quarter ended December 31. The mean expectation of ten analysts for the quarter was for earnings of 45 cents per share. Wall Street expected results to range from 30 cents to 57 cents per share.

  • Revenue was $1.61 billion​; analysts expected $1.48 billion.

  • Ardent Health Partners Inc's reported EPS for the quarter was 81 cents​.

  • The company reported quarterly net income of $114.2 million.

  • Ardent Health Partners Inc shares had fallen by 15.4% this quarter.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 1.7% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Ardent Health Partners Inc is $21.50

This summary was machine generated from LSEG data February 26 at 10:48 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Dec. 31 2024

0.45

0.81

Beat

Sep. 30 2024

0.30

0.17

Missed

Jun. 30 2024

0.30

0.34

Beat

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10